AbbVie Care is a support programme for people taking HUMIRA (adalimumab) in New Zealand.
AbbVie Care provides personalised support to meet each person’s needs.
Support from AbbVie Care is designed to complement the care you receive from your specialist and clinic nurse.
AbbVie Care offers you
An online social community and messaging, connecting you to other kiwis taking HUMIRA
AbbVie Care Nurse access including home visits*, 0800 calls, video calls and online messaging to support with injecting
Ability to order your travel pack and sharps container along with pharmacy disposal of your sharps container
Easy access to information on all you need to know to get the most out of AbbVie Care and HUMIRA e.g. welcome kit and travel information
* Home visits do not cover all of New Zealand. Your AbbVie Care Nurse will be able to discuss this with you when you join AbbVie Care.
IMPORTANT INFORMATION ABOUT HUMIRA: HUMIRA is a prescription medicine containing adalimumab. HUMIRA is available as a single use, pre-filled syringe (containing 20mg or 40mg adalimumab) or single-use pen (containing 40mg adalimumab). It is used in the treatment of patients with rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, enthesitis-related arthritis, psoriatic arthritis, ankylosing spondylitis, non-radiographic axial spondyloarthritis, chronic plaque psoriasis, ulcerative colitis, Crohn’s disease, non-infectious uveitis, and hidradenitis suppurativa. HUMIRA is only used in patients of a specific age group, in diseases of certain severity (e.g. moderate to severe), and/or after some other treatments have been tried (e.g. conventional therapy). HUMIRA has risks and benefits. Refer to the Safety Information contained on this website for further details. If you have any questions about using HUMIRA, ask your healthcare professional and refer to the Consumer Medicine Information (CMI) available here: HUMIRA PEN CMI or HUMIRA Pre-filled Syringe CMI or by calling freephone 0800 900 030. Ask your doctor if HUMIRA is right for you. Use strictly as directed. If symptoms continue, or you have side effects, see your doctor, pharmacist or healthcare professional. HUMIRA is a fully funded medicine under Special Authority for most indications- normal pharmacy prescription charges apply. HUMIRA is not funded for enthesitis-related arthritis, non-radiographic axial spondyloarthritis, ulcerative colitis, uveitis and hidradenitis suppurativa – a pharmacy charge will apply. Normal doctor’s charges apply. AbbVie is the company that brings you HUMIRA (adalimumab). For more information about AbbVie, visit www.AbbVie.co.nz HUMIRA Data Sheet AbbVie Limited, 6th floor, 156-158 Victoria street, Wellington, 6011, New Zealand 0800 900 030. HUMIRA and Destination You are registered trademarks of AbbVie Biotechnology Ltd. NZ-HUM-180062 ver 1 TAPS PP3271 Prepared: April 2019. Copyright © AbbVie Limited.